SPC146

Obinutizumab í öllum gerðum eins og verndað af grunneinkaleyfinu

  • Status:
    Veitt
  • Application date:
    9.2.2016
  • Application published:
    15.3.2016
  • Grant published:
    15.6.2017
  • Max expiry date:
    23.7.2029
  • Next due date:
    30.11.2026
  • Medicine name:
    Gazyvaro
  • Medicine for children:
    No

Timeline

Today
9.2.2016Application
15.3.2016Publication
15.6.2017Registration
4.11.2026Expires

Marketing license

  • IS authorization number:
    EU/1/14/937/001
  • Date:
    15.8.2014
  • Foreign authorization number:
    EU/1/14/937
  • Date:
    23.7.2014

Owner

  • Name:
    Roche Glycart AG
  • Address:
    Wagistrasse 18, Schlieren-Zuerich CH

Agent

  • Name:
    Örn Þór slf.
  • Address:
    Klukkuvöllum 17, 221 Hafnarfirði

Patent

Annual fees

Number

Paid

Expires

Payer

Number: 1

Paid: 11.9.2024

Expires: 4.11.2025

Payer: Árnason Faktor ehf.

Number: 2

Paid: 15.9.2025

Expires: 4.11.2026

Payer: Árnason Faktor ehf.

Upload documents